A LONGITUDINAL-STUDY OF THE CAUSE AND CONSEQUENCES OF CHANGES IN DIVERSIFICATION IN THE UNITED-STATES PHARMACEUTICAL-INDUSTRY 1977-1986

被引:82
作者
HILL, CWL
HANSEN, GS
机构
[1] Graduate School of Business Administration, University of Washington, Seattle, Washington
关键词
D O I
10.1002/smj.4250120303
中图分类号
F [经济];
学科分类号
02 ;
摘要
The paper hypothesizes that diversification by firms based in the pharmaceutical industry during the 1977‐86 time period was primarily undertaken to reduce the risks associated with being dependent upon a technologically dynamic environment. Consistent with this non‐efficiency motive for diversification, declining economic performance is predicted. A longitudinal empirical analysis provides support for these propositions. Copyright © 1991 John Wiley & Sons, Ltd.
引用
收藏
页码:187 / 199
页数:13
相关论文
共 30 条
[1]   DIVERSIFICATION STRATEGIES, BUSINESS CYCLES AND ECONOMIC-PERFORMANCE [J].
AMIT, R ;
LIVNAT, J .
STRATEGIC MANAGEMENT JOURNAL, 1988, 9 (02) :99-110
[2]  
AOKI M, 1984, COOPERATIVE GAME THE
[3]   PERFORMANCE DIFFERENCES IN RELATED AND UNRELATED DIVERSIFIED FIRMS [J].
BETTIS, RA .
STRATEGIC MANAGEMENT JOURNAL, 1981, 2 (04) :379-393
[4]  
Brealey R. A., 1988, PRINCIPLES CORPORATE
[5]   GOODNESS OF FIT IN GENERALIZED LEAST-SQUARES ESTIMATION [J].
BUSE, A .
AMERICAN STATISTICIAN, 1973, 27 (03) :106-108
[6]   CORPORATE ECONOMIC-PERFORMANCE - DIVERSIFICATION STRATEGY VERSUS MARKET-STRUCTURE [J].
CHRISTENSEN, HK ;
MONTGOMERY, CA .
STRATEGIC MANAGEMENT JOURNAL, 1981, 2 (04) :327-343
[7]   INDUSTRY STRUCTURE, MARKET RIVALRY, AND PUBLIC POLICY [J].
DEMSETZ, H .
JOURNAL OF LAW & ECONOMICS, 1973, 16 (01) :1-9
[8]  
EGAN J, 1982, EC PHARM IND
[9]  
Hansen Ronald W., 1979, ISSUES PHARM EC, P151
[10]  
HAYES RH, 1980, HARVARD BUSINESS JUL, P67